BFS vs ESRT

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a missing Altman Z-Score prevents a full distress risk assessment. Despite a high dividend yield of 7.48%, the unsustainable payout ratio of 207% and declining earnings raise serious concerns. Valuation metrics like a P/E of 27.63 and Price/Book of 5.86 are elevated relative to weak growth and poor profitability trends, while the technical trend score of 0/100 signals strong bearish momentum. Although the analyst target price stands at $44.00, minimal coverage (only one analyst) and deteriorating fundamentals limit confidence in this upside.

ESRT presents as a classic value trap, trading below its Graham Number ($5.91) and Book Value (P/B 0.89), yet suffering from a total collapse in technical momentum (0/100). The Piotroski F-Score of 4/9 indicates stable but mediocre financial health, while the massive jump in Forward P/E (from 22.24 to 92.67) signals an expected sharp contraction in future earnings. While the current price offers a margin of safety relative to assets, the structural headwinds of NYC office vacancy and extreme geographic concentration offset the valuation appeal.